XML 557 R175.htm IDEA: XBRL DOCUMENT v3.24.0.1
Loans and advances to customers - Schedule of changes in loss allowance and gross carrying amount (Details) - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year € (193,716) € (163,853)  
Impairment at end of year (243,203) (193,716) € (163,853)
Customers      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year (1,036,004) (972,682)  
Impairment at end of year (1,036,349) (1,036,004) (972,682)
Customers | Financial instruments credit-impaired      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Write-offs 13,847 12,235 9,089
Exchange differences and other changes (168) (418) (529)
Accumulated impairment      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 226 215  
Impairment at end of year 286 226 215
Accumulated impairment | Customers      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 22,684 22,964  
Impairment at end of year 22,788 22,684 22,964
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 22,684 22,964 23,595
Write-offs (13,847) (12,235) (9,089)
Exchange differences and other changes (12) 279 (304)
Impairment at end of year 22,788 22,684 22,964
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Financial instruments not credit-impaired      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 8,753 9,414  
Impairment at end of year 8,550 8,753 9,414
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Financial instruments credit-impaired      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 13,931 13,550  
Impairment at end of year 14,238 13,931 13,550
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Customers      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 22,684 22,964 23,595
To stage 2 from stage 1 2,258 2,333 2,390
To stage 3 from stage 1 3,873 4,029 1,972
To stage 3 from stage 2 1,901 1,380 1,388
To stage 1 from stage 2 756 679 771
To stage 2 from stage 3 638 533 544
To stage 1 from stage 3 157 152 59
Net changes of the exposure and modifications in the credit risk 7,530 5,298 4,386
Write-offs (13,847) (12,235) (9,089)
Exchange differences and other changes (60) 279 (304)
Impairment at end of year 22,788 22,684 22,964
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Customers | Financial instruments not credit-impaired | Stage 1      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 3,626 4,188 4,265
To stage 2 from stage 1 (696) (713) (578)
To stage 3 from stage 1 (405) (557) (237)
To stage 1 from stage 2 (149) (215) (254)
To stage 1 from stage 3 (27) (9) (8)
Net changes of the exposure and modifications in the credit risk 875 414 617
Exchange differences and other changes 20 70 (141)
Impairment at end of year 3,596 3,626 4,188
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Customers | Financial instruments not credit-impaired | Stage 2 and 3      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 5,127 5,226 5,672
To stage 2 from stage 1 2,954 3,046 2,968
To stage 3 from stage 2 (1,820) (1,802) (1,086)
To stage 1 from stage 2 905 894 1,025
To stage 2 from stage 3 (282) (400) (216)
Net changes of the exposure and modifications in the credit risk (557) (1,056) (1,557)
Exchange differences and other changes (127) 207 38
Impairment at end of year 4,954 5,127 5,226
Financial assets at amortised cost and financial assets at fair value through other comprehensive income | Accumulated impairment | Customers | Financial instruments credit-impaired | Stage 2 and 3      
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]      
Impairment at beginning of year 13,931 13,550 13,658
To stage 3 from stage 1 4,278 4,586 2,209
To stage 3 from stage 2 3,721 3,182 2,474
To stage 2 from stage 3 920 933 760
To stage 1 from stage 3 184 161 67
Net changes of the exposure and modifications in the credit risk 7,212 5,940 5,326
Write-offs (13,847) (12,235) (9,089)
Exchange differences and other changes 47 2 (201)
Impairment at end of year € 14,238 € 13,931 € 13,550